Neuroblatoma

New Trial Aims to Boost Kids’ Immune Systems to Fight Neuroblastoma
New Trial Aims to Boost Kids’ Immune Systems to Fight Neuroblastoma 1024 558 Lauren Dembeck

A new cellular therapy approach could improve outcomes and ease the treatment burden for patients and families. Neuroblastoma is rare, with only 700 to 800 new cases diagnosed in the United States each year, but it is the most common extracranial solid tumor in children. Neuroblastoma typically occurs in children younger than 5 years, with…